^
BIOMARKER:

PBRM1 mutation

i
Other names: PBRM1, Polybromo 1, BAF180
Entrez ID:
Related biomarkers:
PBRM1 mutation
Clear Cell Renal Cell Carcinoma
Immunotherapy
Sensitive: B - Late Trials
PBRM1 mutation
Bladder Cancer
pembrolizumab
Sensitive: C3 – Early Trials
PBRM1 mutation
Bladder Cancer
Immunotherapy
Resistant: C3 – Early Trials
PBRM1 mutation
NSCLC
Immunotherapy
Resistant: C3 – Early Trials
PBRM1 mutation
LUAD
Immunotherapy
Resistant: C3 – Early Trials
PBRM1 mutation
RCC
pembrolizumab + lenvatinib
Sensitive: C3 – Early Trials
PBRM1 mutation
RCC
everolimus
Sensitive: C3 – Early Trials
PBRM1 mutation
RCC
bevacizumab + atezolizumab
Resistant: C3 – Early Trials
PBRM1 mutation
RCC
atezolizumab
Resistant: C3 – Early Trials
PBRM1 mutation
Clear Cell Renal Cell Carcinoma
nivolumab
Sensitive: C3 – Early Trials
PBRM1 mutation
Chordoma
tazemetostat
Sensitive: D – Preclinical